Please login to the form below
sales
This page shows the latest sales news and features for those working in and with pharma, biotech and healthcare.
Shire rebuffs Takeda bids, as Allergan bows out
Allergan doesn’t intent to make a formal offer following a dip in its share prices
Latest news
-
P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit
Sales have grown organically by 6% over the last two years, reaching 911m in 2017. ... News of the sale comes amid a flurry of deal-making in the pharma sector, with companies selling and swapping units deemed outside their main areas of interest.
-
Rigel and Ultragenyx claim approvals for rare drugs
to be a much larger market opportunity with blockbuster sales potential. ... patients. He’s predicting sales could reach $336m in 2022. Ultragenyx has also picked up a second rare paediatric disease priority review voucher for the approval, having sold
-
BMS claims rapid FDA nod for Opdivo plus Yervoy in kidney cancer
Data shows the combo can improve survival compared to Pfizer’s Sutent
-
Sanofi sells European generics to Advent for $2.4bn
Sanofi’s total generics sales fell 3.3% to 1.78bn last year, with the declines most apparent in Europe and emerging markets. ... Analysts suggest that Sanofi will re-invest the proceeds from the sale in its pipeline-building exercise, either through
-
Amgen and Novartis migraine drug hits the mark again
the CGRP class could eventually make $4bn in sales by 2026.
More from news
Approximately 35 fully matching, plus 1,215 partially matching documents found.
Latest Intelligence
-
Brexit Means Brexit
The differential destinations of post-Brexit pharma
-
A new era of smart pharma
How smarter pharmaceuticals and pharmacovigilance are transforming healthcare
-
Six degrees of participation
Exploring the ongoing journey to patient empowerment and examining how pharma can play a part in more participatory models of care
-
Health on instalment
Can US-style financial engineering underwrite ultra-expensive gene therapies?
-
Can value-based healthcare take off and reach for the skies?
Are companies willing to contribute to the change in the healthcare system?
More from intelligence
Approximately 20 fully matching, plus 441 partially matching documents found.
Latest appointments
-
Abeona Therapeutics names CEO
Carsten Thiel joins the biopharma from Alexion
-
Zelluna Immunotherapy appoints chief technology officer
Arjan Roozen will consolidate the biotech’s manufacturing strategy
-
Sobi poaches Pfizer’s Fredrick Wetterlundh
He joins the speciality healthcare group as head of human resources
-
Targovax strengthens board of directors
Catherine Wheeler joins from Acetylon Pharmaceutical
-
Dermavant strengthens executive team
David Rubenstein, Richard Peterson, Ariel Jasie and Chris Van Tuyl join the group
More from appointments
Approximately 0 fully matching, plus 790 partially matching documents found.
Latest from PMHub
-
Recent approval for your brand from NICE or SMC? Time to rethink your market access
OUTiCO have successfully delivered numerous pre and post launch projects, and offer flexible, high quality sales teams – to view case studies click here.
-
Creative effectiveness: international work that works
We have expertise in advertising, design, direct response, sales promotion, video and film, experiential, and digital work.
-
Introduction to the manufacturing of biologics
Biopharma made up 22% of big pharma companies’ sales in 2013, with this number being expected to rise to 32% of sales by 2023.
-
Creative effectiveness: how to achieve tangible results
We see the opportunity to use our creative skills and experience to craft a solution that will work inmarket, which will be adopted by the countries and sales teams quickly and
-
How to measure marketing success: profit vs ROI
How to measure effectiveness. 1. Measuring the sales effect . The first step in measuring effectiveness is often the most difficult – calculating the sales effect. ... This is the incremental sales revenue generated by the marketing activity and can
More from PMHub
Approximately 35 fully matching, plus 318 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Great salary and bebefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Project Manager, Medical Communications, London
-
Excellent Salary
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Account Manager – Med Comms – London
-
Salary TBC
- Project Manager, Medical Communications, Oxford
-
Excellent Salary
-
Scientific Director
-
Great salary and bebefits
- Senior Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Group Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Editor – Medical Education Agency – Bucks
-
Salary TBC
Subscribe to our email news alerts
- BenevolentAI raises $115m to fund drug development
- Shire rebuffs Takeda bids, as Allergan bows out
- Abeona Therapeutics names CEO
- Zelluna Immunotherapy appoints chief technology officer
- Spirit Health Group offers new market access consultancy service
- Why heading online for scientific meetings can yield greater HCP engagement
PMHub
CAN advertising
Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...
Latest intelligence
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Quick links
Infographics
